date,title,source
Oct-29-18,Acer Therapeutics Submits NDA for EDSIVO for the Treatment of vEDS,GlobeNewswire
Nov-08-18,Acer Therapeutics to Present at the Evercore ISI HealthConX Conference,GlobeNewswire
Dec-17-18,Acer Therapeutics Appoints Salma Jutt as Chief Commercial Officer,GlobeNewswire
Dec-20-18,Opexa Therapeutics Enters Oversold Territory,Zacks
Dec-26-18,Is This Biotech Stock Turning A Corner? Acer Pops On FDA Acceptance,Investor's Business Daily
Dec-26-18,Acer Therapeutics Announces FDA Acceptance of NDA and Priority Review for EDSIVO for the Treatment of vEDS,GlobeNewswire
